The Science of Childhood Cancer is an interactive, weekly lecture series designed to engage the scientific community on key questions in pediatric cancer research. The series, hosted by the St. Jude Comprehensive Cancer Center, originally launched in August 2020 and features leading experts across the spectrum of basic, translational, clinical and population science. Explore our library of archived lectures sorted by category below, and visit our registration page to receive updates about upcoming live events. You can also see a chronological list of lectures.
-
-
Metabolism and epigenetics as integrated drivers of childhood brain cancer
05/02/2024
Sriram Venneti, MD, PhD
University of Michigan Medical School -
Rising Stars of Cancer Research
03/07/2024
Dissecting epigenetic control of transcription in pediatric cancer
Adam Durbin, MD, PhD
St. Jude Childrens Research Hospital
Organoids in pediatric cancer research
Jarno Drost, PhD
Princess Máxima Center for Pediatric Oncology
Oncode Institute -
Evolution of Our Understanding of WNT and SHH Medulloblastoma
04/20/2023
Amar Gajjar, MD
St. Jude Children's Research Hospital -
Rising Stars of Cancer Research
03/23/2023
CAR T-cells for T-cell Malignancies: Proving and Improving
Maksim Mamonkin, PhD
Baylor College of Medicine
What Will it Take to Make CARTs Effective for Pediatric Brain Tumors?
Giedre Krenciute
St. Jude Children's Research Hospital -
Rising Stars of Cancer Research
11/10/2022
Co-opting the TCR Machinery to Enhance CAR T Cell Efficacy and Specificity
Robbie Majzner
Stanford
The Evolution of Pediatric Gliomas
Pratiti (Mimi) Bandopadhayay
Dana-Farber/Boston -
Oncohistones Organize Chromatin Architecture to Regulate Developmental Programs
08/25/2022
Nada Jabado, MD, PhD
McGill University -
Mapping Childhood Brain Tumor Profiles Onto Normal Development Identifies Novel Therapeutic Vulnerabilities
03/17/2022
Prof. Dr. Stefan M. Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
DKFZ
Heidelberg University Hospital -
Tailoring Medulloblastoma Therapy to Fit the Evolving Molecular Landscape
11/11/2021
Rising Stars of Cancer Research
Giles Robinson, MD
St. Jude Children’s Research Hospital -
Pediatric High-grade Glioma – Novel Drivers Define a Spectrum of New Tumor Subgroups
03/18/2021
David T.W. Jones, PhD
Hopp Children’s Cancer Center (KiTZ) German Cancer Research Center (DKFZ) -
Therapeutic Targeting of Self-Renewal of Medulloblastoma Stem Cells: Strategies for Blocking Recurrence
03/04/2021
Sheila Singh, MD, PhD, FRCS(C)
McMaster Children's Hospital
McMaster University -
Will We Ever Cure Cancer?
02/04/2021
Richard Gilbertson, MD, PhD
University of Cambridge, England -
Targeting Neuron-Glial Interactions in Childhood Brain Cancer
11/12/2020
Michelle Monje, MD, PhD
Stanford University -
Medulloblastomics 2020: Biological & Clinical Insights From 1,000s of Patients
10/08/2020
Paul A. Northcott, PhD
St. Jude Children's Research Hospital
-
-
-
Chromatin and cancer: from mechanisms to emerging therapies
09/05/2024
Charles WM Roberts, Chromatin and cancer: from mechanisms to emerging therapies, Science of Childhood Cancer Lecture Series
-
Wild type and mutant p53 functions
08/29/2024
Guillermina Lozano, Wild type and mutant p53 functions, Science of Childhood Cancer Lecture Series
-
Targeting metabolic vulnerabilities in high-risk childhood cancer using immunotherapy (and other modalities)
04/11/2024
Poul Sorensen, BSc, MD, PhD, FRCPC
The University of British Columbia -
The origins of childhood cancer
11/16/2023
Sam Behjati, BMBCh, PhD
Wellcome Sanger Institute
University of Cambridge -
Rewiring Cancer Drivers to Activate Apoptosis
05/11/2023
Gerald Crabtree, MD
Stanford University -
A New Model of Oncogenic Kinase Signaling via Membraneless Cytoplasmic Protein Granules
09/01/2022
Trever Bivona, MD, PhD
University of California, San Francisco -
Influence of Metabolism on Cancer Progression
09/30/2021
Matt Vander Heiden, MD, PhD
Koch Institute for Integrative Cancer Research at MIT -
Single Cell Atlases as Roadmaps in Pediatric Cancer
03/11/2021
Aviv Regev, PhD
Genentech -
Partitioning of Cancer Therapeutics in Nuclear Condensates
10/22/2020
Richard A. Young, PhD
Whitehead Institute
Massachusetts Institute of Technology (MIT)
Isaac A. Klein, MD, PhD
Dana-Farber Cancer Institute
Whitehead Institute
-
-
-
Rising Stars of Cancer Research
05/09/2024
Rising Stars of Cancer Research
Poverty as a "druggable" target: opportunities and challenges for health equity research
Kira Bona, MD, MPH, Harvard Medical School
Guideline development and delivery of precision-survivorship care
Matt Ehrhardt, MD, MS
St. Jude Children's Research Hospital -
Accelerating therapeutic innovations for children and adolescents with cancer
04/25/2024
Gilles Vassal, MD, PhD
Gustave Roussy Comprehensive Cancer Center, Villejuif, France -
Harnessing Implementation Science to Improve Outcomes for Children with Cancer Who Develop Critical Illness
04/13/2023
Asya Agulnik, MD, MPH
St. Jude Global
St. Jude Children's Research Hospital
-
Strategies to Address Global Inequities in Childhood Cancer Care and Control
10/13/2022
Carlos Rodriguez-Galindo, MD
St. Jude Global
St. Jude Children's Research Hospital -
Pediatric Oncology Drug Development – Learning from Past Successes to Create a Better Future
09/29/2022
Malcolm A. Smith, MD, PhD
National Cancer Institute (NCI) -
Learning From Children: Designing Better Clinical Trials with Their Data - Katherine A. Janeway, MD, MMSc
03/31/2022
Katherine A. Janeway, MD, MMSc
Harvard Medical School
Boston Children's Cancer and Blood Disorders Center
Dana-Farber Cancer Institute -
CAR T Cell Therapies for Childhood Cancer, the University College London Experience
10/28/2021
Martin Pule, MB, FRCPath
University College London -
Successes and Challenges in Pediatric Cancer: The COG Perspective
03/18/2021
Douglas S. Hawkins, MD
University of Washington School of Medicine Seattle Children’s Hospital
-
-
-
The Conformational Landscape of Protein Kinases in Physiology and Disease
05/19/2022
Charalampos Kalodimos, PhD
St. Jude Children's Research Hospital -
What Can We Learn From GWAS Data? Genetic Heterogeneity and Rare Variant Hypothesis of Cancer Risk
04/14/2022
Yutaka Yasui, PhD
St. Jude Children's Research Hospital -
Targeting Hidden Drivers Toward Precision Oncology - Jiyang Yu
03/24/2022
Jiyang Yu, PhD
St. Jude Children's Research Hospital -
Mapping Childhood Brain Tumor Profiles Onto Normal Development Identifies Novel Therapeutic Vulnerabilities
03/17/2022
Prof. Dr. Stefan M. Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
DKFZ
Heidelberg University Hospital -
Deconvoluting the Origins of Acute Leukemia
08/12/2021
Charles G. Mullighan, MBBS (Hons), MSc, MD St. Jude Children’s Research Hospital
-
Data Science Approaches to GPCR Signaling and Personalized Medicine
04/15/2021
Madan Babu, PhD, FRSC
St. Jude Children’s Research Hospital -
Single Cell Atlases as Roadmaps in Pediatric Cancer
03/11/2021
Aviv Regev, PhD
Genentech -
Genomic Variants in Pediatric Cancer: Landscape, Precision Oncology, and Data Sharing Ecosystem
01/28/2021
Jinghui Zhang, PhD
St. Jude Children’s Research Hospital -
Medulloblastomics 2020: Biological & Clinical Insights From 1,000s of Patients
10/08/2020
Paul A. Northcott, PhD
St. Jude Children's Research Hospital
-
-
-
Chromatin and cancer: from mechanisms to emerging therapies
09/05/2024
Charles WM Roberts, Chromatin and cancer: from mechanisms to emerging therapies, Science of Childhood Cancer Lecture Series
-
Metabolism and epigenetics as integrated drivers of childhood brain cancer
05/02/2024
Sriram Venneti, MD, PhD
University of Michigan Medical School -
Non-genetic mechanisms of clonal dominance in normal and malignant haematopoiesis
03/14/2024
Mark Dawson, MBBS (Hons), BMedSci, FRACP, FRCPA, PhD
University of Melbourne -
Rising Stars of Cancer Research
03/07/2024
Dissecting epigenetic control of transcription in pediatric cancer
Adam Durbin, MD, PhD
St. Jude Childrens Research Hospital
Organoids in pediatric cancer research
Jarno Drost, PhD
Princess Máxima Center for Pediatric Oncology
Oncode Institute -
Understanding and targeting the non-coding regulatory genome
02/15/2024
Jian Xu, PhD
Center of Excellence for Leukemia Studies
Department of Pathology
St. Jude Children’s Research Hospital -
Mechanisms of chromatin regulation by EWS fusion proteins
04/06/2023
Miguel N. Rivera, MD
Harvard Medical School
Massachusetts General Hospital -
HOX-high Leukemias in Childhood
03/30/2023
Kathrin M. Bernt, MD
The Children's Hospital of Philadelphia
University of Pennsylvania Abramson Cancer Center (NCI designated) -
Oncohistones Organize Chromatin Architecture to Regulate Developmental Programs
08/25/2022
Nada Jabado, MD, PhD
McGill University -
Epigenetic Mechanisms of Tumorigenesis
10/14/2021
Bradley Bernstein, MD, PhD
Dana-Farber Cancer Institute
Broad Institute of Harvard and MIT -
Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Human Cancer
05/06/2021
Cigall Kadoch, PhD
Dana-Farber Cancer Institute and Harvard Medical School -
Chromatin Complexes as Therapeutic Opportunities in Cancer
02/11/2021
Scott Armstrong, MD, PhD
Dana-Farber Cancer Institute
Harvard Medical School -
3D Chromosomal Organization in Pediatric Leukemia: Impact for Drug Response and Disease Progression
10/01/2020
Iannis Aifantis, PhD
NYU Grossman School of Medicine -
Phase Separation in Gene Transcription: From the Nucleolus to Aberrant Transcription in Leukemia
09/03/2020
Richard W. Kriwacki, PhD
St. Jude Children's Research Hospital -
Chromatin Remodeler Mutations in Cancer: Mechanisms and Therapeutic Vulnerabilities
08/20/2020
Charles W.M. Roberts, MD, PhD
St. Jude Children's Research Hospital
-
-
-
Diagnosis of leukemia: from phenotype to genotype to artificial intelligence
09/12/2024
Torsten Haferlach, Diagnosis of leukemia: from phenotype to genotype to artificial intelligence, Science of Childhood Cancer Lecture Series
-
Rising Stars of Cancer Research
08/15/2024
Rising Stars of Cancer Research
Decoding CAR T Cell Phenotype Using Combinatorial Signaling Motif Libraries and Machine Learning
Kyle Daniels, PhD
Stanford University School of Medicine
Targeting transcription factors to augment CAR T cell fitness
Evan Weber, PhD
University of Pennsylvania, Children’s Hospital of Philadelphia -
Recent results from translational and clinical studies in childhood acute lymphoblastic leukemia in the Princess Máxima Center
08/08/2024
Rob Pieters, MD PhD MSc
Chief Medical Officer
Princess Máxima Center for Pediatric Oncology -
Stem cell programs in high risk leukemias
03/28/2024
Kai Tan, PhD
Children’s Hospital of Philadelphia
University of Pennsylvania Perelman School of Medicine -
Understanding treatment resistance and relapse in ALL through single cell studies
03/21/2024
Kara Davis, DO
Stanford University -
Non-genetic mechanisms of clonal dominance in normal and malignant haematopoiesis
03/14/2024
Mark Dawson, MBBS (Hons), BMedSci, FRACP, FRCPA, PhD
University of Melbourne -
Beyond owl eyes - advances in pediatric and AYA Hodgkin lymphoma
02/29/2024
Sharon Castellino, MD, MSc
Emory University School of Medicine
Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta -
Understanding and targeting the non-coding regulatory genome
02/15/2024
Jian Xu, PhD
Center of Excellence for Leukemia Studies
Department of Pathology
St. Jude Children’s Research Hospital -
Novel venetoclax combinations for relapsed pediatric leukemia
08/17/2023
Rising Stars of Cancer Research
Seth Karol, MD
St. Jude Children's Research Hospital -
Hereditary Predisposition to Cancer: At the Tip of the Iceberg
05/25/2023
Kim E. Nichols, MD
St. Jude Children's Research Hospital -
New mechanistic insights into the development of pediatric myeloid tumors
05/18/2023
Jeffery M. Klco, MD, PhD
St. Jude Children's Research Hospital -
Emerging Therapies for Pediatric Leukemia
05/04/2023
Sarah K Tasian, MD
University of Pennsylvania School of Medicine
Children’s Hospital of Philadelphia -
HOX-high Leukemias in Childhood
03/30/2023
Kathrin M. Bernt, MD
The Children's Hospital of Philadelphia
University of Pennsylvania Abramson Cancer Center (NCI designated) -
Rising Stars of Cancer Research
03/23/2023
CAR T-cells for T-cell Malignancies: Proving and Improving
Maksim Mamonkin, PhD
Baylor College of Medicine
What Will it Take to Make CARTs Effective for Pediatric Brain Tumors?
Giedre Krenciute
St. Jude Children's Research Hospital -
Clonal Hematopoiesis and the Origins of Blood Cancers
02/16/2023
Benjamin Ebert, MD, PhD
Harvard Medical School
Dana-Farber Cancer Institute -
Targeting Bcl-2 Family Proteins in Leukemia
10/06/2022
Marina Konopleva, MD, PhD
Translational Blood Cancer Institute
University of Texas MD Anderson Cancer Center -
From Bedside to Bench and Back to Bedside: Travels in the Systems Biology of GVHD
09/22/2022
Leslie S. Kean, MD, PhD
Boston Children’s Hospital
Dana-Farber Cancer Institute
Harvard Medical School -
Unraveling the Heterogeneity of Acute Lymphoblastic Leukemia Through the Lens of Pharmacogenomics
05/05/2022
Jun J. Yang, PhD
St. Jude Children's Research Hospital -
Identify Novel Therapeutic Opportunities in Pediatric Cancers Using High-Resolution CRISPR Tiling Scans
04/28/2022
David Chen, PhD
City of Hope Cancer Center -
Clonal Evolution and Somatic Reversion in Genetic Predisposition to TP53-Mutated MDS
02/17/2022
Akiko Shimamura, MD, PhD
Harvard Medical School
Dana Farber/Boston Children’s Cancer and Blood Disorders Center -
What Will it Take To Cure Every Child with Acute Lymphoblastic Leukemia?
10/21/2021
Mignon Loh, MD
Benioff Children’s Hospital, UCSF, San Francisco, CA -
The Biology, Diagnosis, and Management of T-Cell Acute Lymphoblastic Leukemia and Lymphoma
09/16/2021
David T. Teachey, MD
The Children’s Hospital of Philadelphia
University of Pennsylvania Perelman School of Medicine -
Deconvoluting the Origins of Acute Leukemia
08/12/2021
Charles G. Mullighan, MBBS (Hons), MSc, MD St. Jude Children’s Research Hospital
-
Mechanisms of Leukemogenesis in Children with Down Syndrome
02/25/2021
John Crispino, PhD, MBA
St. Jude Children’s Research Hospital -
Chromatin Complexes as Therapeutic Opportunities in Cancer
02/11/2021
Scott Armstrong, MD, PhD
Dana-Farber Cancer Institute
Harvard Medical School -
3D Chromosomal Organization in Pediatric Leukemia: Impact for Drug Response and Disease Progression
10/01/2020
Iannis Aifantis, PhD
NYU Grossman School of Medicine -
Phase Separation in Gene Transcription: From the Nucleolus to Aberrant Transcription in Leukemia
09/03/2020
Richard W. Kriwacki, PhD
St. Jude Children's Research Hospital -
The Future of CAR T Cells for Hematologic Malignancies: Beyond Antigen Targeting Beyond Antigen Targeting
08/27/2020
Terry J. Fry, MD
University of Colorado School of Medicine
Children’s Hospital Colorado, Center for Cancer and Blood Disorders
-
-
-
Rising Stars of Cancer Research
08/15/2024
Rising Stars of Cancer Research
Decoding CAR T Cell Phenotype Using Combinatorial Signaling Motif Libraries and Machine Learning
Kyle Daniels, PhD
Stanford University School of Medicine
Targeting transcription factors to augment CAR T cell fitness
Evan Weber, PhD
University of Pennsylvania, Children’s Hospital of Philadelphia -
Engineered Cell Therapy for Pediatric Cancer
08/08/2024
Stephen Gottschalk, MD
Chair, Department of Bone Marrow Transplantation and Cellular Therapy
Co-Director, Center of Excellence for Pediatric Immuno-Oncology
St. Jude Children's Research Hospital -
Targeting metabolic vulnerabilities in high-risk childhood cancer using immunotherapy (and other modalities)
04/11/2024
Poul Sorensen, BSc, MD, PhD, FRCPC
The University of British Columbia -
Neuroblastoma: The power of immunotherapy in pediatric malignancy
11/02/2023
Julie Park, MD
St. Jude Children's Research Hospital -
Sounding an alarm: Innate immunity makes cancer immunogenic
08/31/2023
Judy Lieberman, MD, PhD
Boston Children's Hospital
Harvard Medical School -
Translating the self/nonself discrimination problem in cancer
08/24/2023
Benjamin Greenbaum, PhD
Memorial Sloan Kettering Cancer Center
Weill Cornell Medicine -
Emerging Therapies for Pediatric Leukemia
05/04/2023
Sarah K Tasian, MD
University of Pennsylvania School of Medicine
Children’s Hospital of Philadelphia -
Rising Stars of Cancer Research
03/23/2023
CAR T-cells for T-cell Malignancies: Proving and Improving
Maksim Mamonkin, PhD
Baylor College of Medicine
What Will it Take to Make CARTs Effective for Pediatric Brain Tumors?
Giedre Krenciute
St. Jude Children's Research Hospital -
Rising Stars of Cancer Research
11/10/2022
Co-opting the TCR Machinery to Enhance CAR T Cell Efficacy and Specificity
Robbie Majzner
Stanford
The Evolution of Pediatric Gliomas
Pratiti (Mimi) Bandopadhayay
Dana-Farber/Boston -
Designing and Developing Pediatric Cancer-Specific Immunotherapies
09/08/2022
John M. Maris, MD
Perelman School of Medicine
University of Pennsylvania -
Engineered T cells for Cancer Therapy
08/11/2022
Carl H. June, MD
Perelman School of Medicine, University of Pennsylvania -
Functional Genomics of T-Cell Metabolism and Immuno-oncology
03/10/2022
Hongbo Chi, PhD
St. Jude Children's Research Hospital -
CAR T Cell Therapies for Childhood Cancer, the University College London Experience
10/28/2021
Martin Pule, MB, FRCPath
University College London -
Chimeric Antigen Receptor-Redirected Macrophages for the Treatment of Solid Tumors
10/07/2021
Saar Gill, MBBS, PhD, FRACP
University of Pennsylvania Perelman School of Medicine -
Organized Destruction and Destructive Organization: The Diversity of Immune Responses Towards Tumors and Pathogens
11/05/2020
Paul G. Thomas, PhD
St. Jude Children's Research Hospital -
The Future of CAR T Cells for Hematologic Malignancies: Beyond Antigen Targeting Beyond Antigen Targeting
08/27/2020
Terry J. Fry, MD
University of Colorado School of Medicine
Children’s Hospital Colorado, Center for Cancer and Blood Disorders -
CAR T Cells: On the Road to Synthetic Immunity
08/13/2020
Michel Sadelain, MD, PhD
Memorial Sloan-Kettering Cancer Center
-
-
-
Accelerating therapeutic innovations for children and adolescents with cancer
04/25/2024
Gilles Vassal, MD, PhD
Gustave Roussy Comprehensive Cancer Center, Villejuif, France -
Opportunities and challenges in pediatric oncology drug development: Lessons learned from the biopharmaceutical industry
10/12/2023
Sam Blackman, MD, PhD
Day One Biopharmaceuticals -
Hereditary Predisposition to Cancer: At the Tip of the Iceberg
05/25/2023
Kim E. Nichols, MD
St. Jude Children's Research Hospital -
The Lifetime Impact of Childhood Cancer and Cancer Therapy: The Childhood Cancer Survivor Study
10/27/2022
Greg Armstrong
St. Jude Children's Research Hospital -
Strategies to Address Global Inequities in Childhood Cancer Care and Control
10/13/2022
Carlos Rodriguez-Galindo, MD
St. Jude Global
St. Jude Children's Research Hospital -
Learning From Children: Designing Better Clinical Trials with Their Data - Katherine A. Janeway, MD, MMSc
03/31/2022
Katherine A. Janeway, MD, MMSc
Harvard Medical School
Boston Children's Cancer and Blood Disorders Center
Dana-Farber Cancer Institute -
Successes and Challenges in Pediatric Cancer: The COG Perspective
03/18/2021
Douglas S. Hawkins, MD
University of Washington School of Medicine Seattle Children’s Hospital -
Will We Ever Cure Cancer?
02/04/2021
Richard Gilbertson, MD, PhD
University of Cambridge, England
-
-
-
Wild type and mutant p53 functions
08/29/2024
Guillermina Lozano, Wild type and mutant p53 functions, Science of Childhood Cancer Lecture Series
-
Engineered Cell Therapy for Pediatric Cancer
08/08/2024
Stephen Gottschalk, MD
Chair, Department of Bone Marrow Transplantation and Cellular Therapy
Co-Director, Center of Excellence for Pediatric Immuno-Oncology
St. Jude Children's Research Hospital -
Rising Stars of Cancer Research
03/07/2024
Dissecting epigenetic control of transcription in pediatric cancer
Adam Durbin, MD, PhD
St. Jude Childrens Research Hospital
Organoids in pediatric cancer research
Jarno Drost, PhD
Princess Máxima Center for Pediatric Oncology
Oncode Institute -
Neuroblastoma: The power of immunotherapy in pediatric malignancy
11/02/2023
Julie Park, MD
St. Jude Children's Research Hospital -
Genomic analysis of osteosarcoma: Making sense of a complex genome to advance translational research and targeted therapy
10/05/2023
Alejandro Sweet-Cordero, MD
University of California-San Francisco -
Advancing Outcomes for Patients with Neuroblastoma
09/21/2023
Sara Federico, MD
St. Jude Children's Research Hospital -
Childhood neuroblastoma: evolution and malignant progression
09/14/2023
Frank Westermann, MD
German Cancer Research Center (DKFZ)
Hopp Children’s Cancer Center (KiTZ)
Heidelberg, Germany -
Pushing for new biology and cancer therapies in rhabdomyosarcoma
09/07/2023
David Langenau, PhD
Harvard Medical School
Mass General Cancer Center and Pathology -
Mechanisms of chromatin regulation by EWS fusion proteins
04/06/2023
Miguel N. Rivera, MD
Harvard Medical School
Massachusetts General Hospital -
Discovering and Targeting Neuroblastoma Vulnerabilities: ALK Inhibition as a Paradigm
03/03/2022
Yaël Mossé, MD
Perelman School of Medicine
University of Pennsylvania
Children's Hospital of Philadelphia -
Chimeric Antigen Receptor-Redirected Macrophages for the Treatment of Solid Tumors
10/07/2021
Saar Gill, MBBS, PhD, FRACP
University of Pennsylvania Perelman School of Medicine -
Sunlight and Skin: Lessons for Melanoma Therapeutics From Its Unique Pathogenesis
09/23/2021
David E. Fisher MD, PhD
Massachusetts General Hospital
Harvard Medical School -
Modulation of the Activity of the Dominant Oncogene EWS-FLI1 by Germline Polymorphisms and Cohesin Mutations
08/26/2021
Olivier Delattre, MD, PhD
Institut Curie, Paris, France -
Identification of Biomarkers, Models and Targets to Improve Outcomes and Precision Approaches for Neuroblastoma
08/19/2021
Meredith Irwin, MD
University of Toronto -
Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Human Cancer
05/06/2021
Cigall Kadoch, PhD
Dana-Farber Cancer Institute and Harvard Medical School -
A First-generation Pediatric Cancer Dependency Map
04/29/2021
Kimberly Stegmaier, MD
Harvard Medical School
Dana-Farber Cancer Institute -
Harnessing Lineage Plasticity for the Treatment of Neuroblastoma
10/29/2020
Rani George MD, PhD
Dana-Farber Cancer Institute/Boston Children's Hospital -
Chromatin Remodeler Mutations in Cancer: Mechanisms and Therapeutic Vulnerabilities
08/20/2020
Charles W.M. Roberts, MD, PhD
St. Jude Children's Research Hospital
-
-
-
Improving Cognitive Outcomes for Children Treated for Cancer: Moving Beyond the Cure
05/16/2024
Heather Conklin, PhD
St. Jude Children's Research Hospital -
Rising Stars of Cancer Research
05/09/2024
Rising Stars of Cancer Research
Poverty as a "druggable" target: opportunities and challenges for health equity research
Kira Bona, MD, MPH, Harvard Medical School
Guideline development and delivery of precision-survivorship care
Matt Ehrhardt, MD, MS
St. Jude Children's Research Hospital -
Quality of care for adolescents and young adults with advanced cancer
04/04/2024
Jenny Mack, MD, MPH
Harvard Medical School
Dana-Farber Cancer Institute -
Beyond owl eyes - advances in pediatric and AYA Hodgkin lymphoma
02/29/2024
Sharon Castellino, MD, MSc
Emory University School of Medicine
Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta -
Emerging paradigms in cancer survivorship across the lifespan
11/09/2023
Saro Armenian, DO, MPH
City of Hope Comprehensive Cancer Center -
The financial burden of surviving childhood cancer
09/28/2023
Paul Nathan, MD, MSc
The Hospital for Sick Children
University of Toronto -
Harnessing Implementation Science to Improve Outcomes for Children with Cancer Who Develop Critical Illness
04/13/2023
Asya Agulnik, MD, MPH
St. Jude Global
St. Jude Children's Research Hospital
-
Psychological and Biobehavioral Health Outcomes in Survivors of Childhood Cancer
03/09/2023
Tara M. Brinkman, PhD
St. Jude Children’s Research Hospital -
Prognostic Significance of Aberrant Body Composition and Musculoskeletal Deficits in Childhood Cancer Survivors
11/17/2022
Sogol Mostoufi-Moab, MD, MSCE
Perelman School of Medicine
University of Pennsylvania
Children’s Hospital of Philadelphia -
The Lifetime Impact of Childhood Cancer and Cancer Therapy: The Childhood Cancer Survivor Study
10/27/2022
Greg Armstrong
St. Jude Children's Research Hospital -
Genetic Susceptibility to Subsequent Neoplasms Following Childhood Cancer
05/12/2022
S Lindsay M. Morton, PhD
Division of Cancer Epidemiology and Genetics
National Cancer Institute -
What Can We Learn From GWAS Data? Genetic Heterogeneity and Rare Variant Hypothesis of Cancer Risk
04/14/2022
Yutaka Yasui, PhD
St. Jude Children's Research Hospital -
Secondary Breast Cancer: A Paradigm for Survivorship Research
02/10/2022
Kevin Oeffinger, MD
Duke University -
Interventions to Prevent or Remediate Frailty in Childhood Cancer Survivors
11/04/2021
Kirsten K. Ness, PT, PhD, FAPTA
St. Jude Children’s Research Hospital -
The Role of Survivorship Research in Advancing Childhood Cancer Care and Quality of Survival
09/02/2021
Melissa M. Hudson, MD
St. Jude Children’s Research Hospital -
Genetic and Epigenetic Approaches Towards Understanding Risk of Chronic Health Conditions Among Survivors of Childhood Cancer
04/22/2021
Zhaoming Wang, PhD St. Jude Children’s Research Hospital
-
Identifying Strategies to Improve HPV Vaccination Among Childhood Cancer Survivors
04/08/2021
Anne Kirchhoff, PhD, MPH
University of Utah/Huntsman Cancer Institute -
Financial Hardship After Childhood Cancer
02/18/2021
Robin Yabroff, PhD, MBA
American Cancer Society -
Emerging Late Effects of Targeted Molecular Therapies
11/19/2020
Dr. Eric Chow
Stanford University -
Cognitive Outcomes of Childhood Cancer: Neurophysiology, Biomarkers and Interventions
09/24/2020
Kevin R. Krull, PhD
St. Jude Children's Research Hospital
-
-
-
Understanding treatment resistance and relapse in ALL through single cell studies
03/21/2024
Kara Davis, DO
Stanford University -
Opportunities and challenges in pediatric oncology drug development: Lessons learned from the biopharmaceutical industry
10/12/2023
Sam Blackman, MD, PhD
Day One Biopharmaceuticals -
Genomic analysis of osteosarcoma: Making sense of a complex genome to advance translational research and targeted therapy
10/05/2023
Alejandro Sweet-Cordero, MD
University of California-San Francisco -
Pediatric Oncology Drug Development – Learning from Past Successes to Create a Better Future
09/29/2022
Malcolm A. Smith, MD, PhD
National Cancer Institute (NCI) -
Designing and Developing Pediatric Cancer-Specific Immunotherapies
09/08/2022
John M. Maris, MD
Perelman School of Medicine
University of Pennsylvania -
Unraveling the Heterogeneity of Acute Lymphoblastic Leukemia Through the Lens of Pharmacogenomics
05/05/2022
Jun J. Yang, PhD
St. Jude Children's Research Hospital -
Identify Novel Therapeutic Opportunities in Pediatric Cancers Using High-Resolution CRISPR Tiling Scans
04/28/2022
David Chen, PhD
City of Hope Cancer Center -
Targeting Hidden Drivers Toward Precision Oncology - Jiyang Yu
03/24/2022
Jiyang Yu, PhD
St. Jude Children's Research Hospital -
Discovering and Targeting Neuroblastoma Vulnerabilities: ALK Inhibition as a Paradigm
03/03/2022
Yaël Mossé, MD
Perelman School of Medicine
University of Pennsylvania
Children's Hospital of Philadelphia -
Tailoring Medulloblastoma Therapy to Fit the Evolving Molecular Landscape
11/11/2021
Rising Stars of Cancer Research
Giles Robinson, MD
St. Jude Children’s Research Hospital -
What Will it Take To Cure Every Child with Acute Lymphoblastic Leukemia?
10/21/2021
Mignon Loh, MD
Benioff Children’s Hospital, UCSF, San Francisco, CA -
A First-generation Pediatric Cancer Dependency Map
04/29/2021
Kimberly Stegmaier, MD
Harvard Medical School
Dana-Farber Cancer Institute -
Data Science Approaches to GPCR Signaling and Personalized Medicine
04/15/2021
Madan Babu, PhD, FRSC
St. Jude Children’s Research Hospital -
Genomic Variants in Pediatric Cancer: Landscape, Precision Oncology, and Data Sharing Ecosystem
01/28/2021
Jinghui Zhang, PhD
St. Jude Children’s Research Hospital -
Partitioning of Cancer Therapeutics in Nuclear Condensates
10/22/2020
Richard A. Young, PhD
Whitehead Institute
Massachusetts Institute of Technology (MIT)
Isaac A. Klein, MD, PhD
Dana-Farber Cancer Institute
Whitehead Institute
-
Comprehensive Cancer Center
St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children.
